Chemed Corp(CHE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 25.92 | EPS (ttm) | 19.91 | Insider Own | 1.96% | Shs Outstand | 13.0M | Perf Week | -1.62% |
| Market Cap | 6.74B | Forward P/E | 18.75 | EPS next Y | 7.85% | Insider Trans | -4.69% | Shs Float | 12.8M | Perf Month | -4.63% |
| Enterprise Value | 7.03B | PEG | 1.73 | EPS next Q | 6.48 | Inst Own | 105.81% | Short Float | 4.41% | Perf Quarter | 22.6% |
| Income | 0.27B | P/S | 2.6 | EPS this Y | 18.43% | Inst Trans | -2.81% | Short Ratio | 3.21 | Perf Half Y | 29.14% |
| Sales | 2.60B | P/B | 8.09 | EPS next 5Y | 10.82% | ROA | 16.68% | Short Interest | 0.56M | Perf YTD | 20.59% |
| Book/sh | 63.81 | P/C | 167.67 | EPS past 3/5Y | 3.52% -1.2% | ROE | 27.11% | 52W High | -7.37% ($557.00) | Perf Year | 12.68% |
| Cash/sh | 3.08 | P/FCF | 20.84 | Sales past 3/5Y | 5.82% 4% | ROIC | 25.37% | 52W Low | 41.28% ($365.20) | Perf 3Y | 2.69% |
| Dividend Est. | $2.46 (0.48%) | EV/EBITDA | 16.9 | EPS Y/Y TTM | 1.56% | Gross Margin | 30.44% | Volatility(W/M) | 2.52% 2.68% | Perf 5Y | 8.52% |
| Dividend TTM | 2.5 | EV/Sales | 2.71 | Sales Y/Y TTM | 3.31% | Oper. Margin | 13.47% | ATR (14) | 14.2 | Perf 10Y | 275.39% |
| Dividend Ex-Date | 2026/8/17 | Quick Ratio | 0.89 | EPS Q/Q | 43.67% | Profit Margin | 10.6% | RSI (14) | 44.08 | Recom | 2.8 |
| Dividend Gr. 3/5Y | 14.13% 10.76% | Current Ratio | 0.91 | Sales Q/Q | 8.8% | SMA20 | -2.15% ($527.31) | Beta | 0.51 | Target Price | $552 |
| Payout | 11.99% | Debt/Eq | 0.4 | Earnings | 2026/7/28 | SMA50 | -0.82% ($520.24) | Rel Volume | 0.47 | Prev Close | $514.4 |
| Employees | 15811 | LT Debt/Eq | 0.31 | EPS/Sales Surpr. | 8.21% 1.24% | SMA200 | 14.8% ($449.45) | Avg Volume(3M) | 0.18M | Price | $515.97 |
| IPO | 1982/6/29 | Option/Short | Yes/Yes | Trades | 3462 | Volume | 81,821 | Change | 0.31% |
Company
CHE is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US-based company that operates two businesses side by side: hospice (end-of-life care) medical services and plumbing/sewer repair services. It owns two distinctly different businesses — one of the largest hospice operations in the US and a plumbing repair franchise — making it a diversified name whose performance is tied to both aging-driven hospice demand and plumbing service demand. It is also known for paying dividends.
Over the past 1 year, on the higher side
7% below its 1-year high.
CHE makes money exceptionally well
13.47% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +18.4% this year.
Tap to view numbers
The price looks about right
Trading at 25.9 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +2.7% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.48% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 105.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $7B.
FAQ
What kind of company is CHE?
CHE belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of CHE?
The market cap of CHE is approximately $6.7B, ranking 1,172 within its sector.
Does CHE pay dividends?
CHE has a dividend yield of approximately 0.48%, with an annual dividend of $2.46.
What is the P/E ratio of CHE?
CHE has a P/E ratio of approximately 25.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CHE?
CHE has recorded a 52-week high of $557.00 and a low of $365.20.